{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:43:05Z","timestamp":1793396585661,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010215","name":"German Diabetes Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010215","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FoeFoLe, LMU Munich"},{"name":"German Society of Internal Medicine"},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Else Kr\u00f6ner-Fresenius-Stiftung (EKFS)."},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Innate lymphoid cells (ILCs) are key organizers of tissue immune responses and regulate tissue development, repair, and pathology. Persistent clinical sequelae beyond 12\u00a0weeks following acute COVID-19 disease, named post-COVID syndrome (PCS), are increasingly recognized in convalescent individuals. ILCs have been associated with the severity of COVID-19 symptoms but their role in the development of PCS remains poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Here, we used multiparametric immune phenotyping, finding expanded circulating ILC precursors (ILCPs) and concurrent decreased group 2 innate lymphoid cells (ILC2s) in PCS patients compared to well-matched convalescent control groups at\u2009&gt;\u20093\u00a0months after infection or healthy controls. Patients with PCS showed elevated expression of chemokines and cytokines associated with trafficking of immune cells (CCL19\/MIP-3b, FLT3-ligand), endothelial inflammation and repair (CXCL1, EGF, RANTES, IL-1RA, PDGF-AA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results define immunological parameters associated with PCS and might help find biomarkers and disease-relevant therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-023-02164-y","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T13:02:27Z","timestamp":1707310947000},"page":"1087-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Persistent immune abnormalities discriminate post-COVID syndrome from convalescence"],"prefix":"10.1007","volume":"52","author":[{"given":"Julia","family":"Sbierski-Kind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schlickeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gr\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pleimelding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Gilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I. M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Benesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pernpruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Valdinoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Adorjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Seybold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Roider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Post COVID Care and KoCo19 study groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"2164_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","volume":"15","author":"DV Clark","year":"2015","unstructured":"Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15:905\u201312. https:\/\/doi.org\/10.1016\/S1473-3099(15)70152-0.","journal-title":"Lancet Infect Dis"},{"key":"2164_CR2","doi-asserted-by":"publisher","unstructured":"A Post-Graduate Lecture ON THE NERVOUS SEQUEL\u00c6 OF INFLUENZA. Lancet 1893;142:73\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(00)65088-2.","DOI":"10.1016\/S0140-6736(00)65088-2"},{"key":"2164_CR3","doi-asserted-by":"publisher","unstructured":"Fluge \u00d8, Tronstad KJ, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Clin Invest 2021. https:\/\/doi.org\/10.1172\/JCI150377.","DOI":"10.1172\/JCI150377"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijcard.2011.10.030","volume":"154","author":"DJ Newton","year":"2012","unstructured":"Newton DJ, Kennedy G, Chan KKF, Lang CC, Belch JJF, Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol. 2012;154:335\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2011.10.030.","journal-title":"Int J Cardiol"},{"key":"2164_CR5","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2020.22717","volume":"324","author":"SD Datta","year":"2020","unstructured":"Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251\u20132. https:\/\/doi.org\/10.1001\/jama.2020.22717.","journal-title":"JAMA"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"m4938","DOI":"10.1136\/bmj.m4938","volume":"371","author":"M Sivan","year":"2020","unstructured":"Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. https:\/\/doi.org\/10.1136\/bmj.m4938.","journal-title":"BMJ"},{"key":"2164_CR7","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long covid\u2014mechanisms, risk factors, and management. BMJ. 2021;374:n1648. https:\/\/doi.org\/10.1136\/bmj.n1648.","journal-title":"BMJ"},{"key":"2164_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cid\/ciac283","volume":"75","author":"I Margalit","year":"2022","unstructured":"Margalit I, Yelin D, Sagi M, Rahat MM, Sheena L, Mizrahi N, et al. Risk factors and multidimensional assessment of long coronavirus disease fatigue: a nested case-control study. Clin Infect Dis. 2022;75:1688\u201397. https:\/\/doi.org\/10.1093\/cid\/ciac283.","journal-title":"Clin Infect Dis"},{"key":"2164_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","volume":"28","author":"J Choutka","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01810-6.","journal-title":"Nat Med"},{"key":"2164_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","volume":"54","author":"S Kreutmair","year":"2021","unstructured":"Kreutmair S, Unger S, N\u00fa\u00f1ez NG, Ingelfinger F, Alberti C, De Feo D, et al. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021;54:1578-1593.e5. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.002.","journal-title":"Immunity"},{"key":"2164_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","volume":"54","author":"L Bergamaschi","year":"2021","unstructured":"Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54:1257-1275.e8. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.010.","journal-title":"Immunity"},{"key":"2164_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12967-020-02646-9","volume":"18","author":"M Blot","year":"2020","unstructured":"Blot M, Bour J-B, Quenot JP, Bourredjem A, Nguyen M, Guy J, et al. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. J Transl Med. 2020;18:457. https:\/\/doi.org\/10.1186\/s12967-020-02646-9.","journal-title":"J Transl Med"},{"key":"2164_CR13","doi-asserted-by":"crossref","unstructured":"Lim J, Puan KJ, Wang LW, Teng KWW, Loh CY, Tan KP, et al. Data-driven analysis of COVID-19 reveals persistent immune abnormalities in convalescent severe individuals. Front Immunol 2021;12.","DOI":"10.3389\/fimmu.2021.710217"},{"key":"2164_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395:1417\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5.","journal-title":"The Lancet"},{"key":"2164_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1126\/sciimmunol.abk1741","volume":"6","author":"IS Cheon","year":"2022","unstructured":"Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2022;6:1741. https:\/\/doi.org\/10.1126\/sciimmunol.abk1741.","journal-title":"Sci Immunol."},{"key":"2164_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.09.22278592","author":"J Klein","year":"2022","unstructured":"Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of Long COVID identified through immune profiling. MedRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.08.09.22278592.","journal-title":"MedRxiv"},{"key":"2164_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210\u20136. https:\/\/doi.org\/10.1038\/s41590-021-01113-x.","journal-title":"Nat Immunol"},{"key":"2164_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature. 2010;463:540\u20134. https:\/\/doi.org\/10.1038\/nature08636.","journal-title":"Nature"},{"key":"2164_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174:1054\u201366. https:\/\/doi.org\/10.1016\/j.cell.2018.07.017.","journal-title":"Cell"},{"key":"2164_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135:626\u201335. https:\/\/doi.org\/10.1016\/j.jaci.2014.11.001.","journal-title":"J Allergy Clin Immunol"},{"key":"2164_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.immuni.2021.12.014","volume":"55","author":"KM Cautivo","year":"2022","unstructured":"Cautivo KM, Matatia PR, Lizama CO, Mroz NM, Dahlgren MW, Yu X, et al. Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity. 2022;55:254-271.e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.014.","journal-title":"Immunity"},{"key":"2164_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coi.2018.05.008","volume":"54","author":"MW Dahlgren","year":"2018","unstructured":"Dahlgren MW, Molofsky AB. All along the watchtower: group 2 innate lymphoid cells in allergic responses. Curr Opin Immunol. 2018;54:13\u20139.","journal-title":"Curr Opin Immunol"},{"key":"2164_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41423-020-00596-2","volume":"18","author":"A Gomez-Cadena","year":"2021","unstructured":"Gomez-Cadena A, Spehner L, Kroemer M, Khelil MB, Bouiller K, Verdeil G, et al. Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment. Cell Mol Immunol. 2021;18:484\u20136. https:\/\/doi.org\/10.1038\/s41423-020-00596-2.","journal-title":"Cell Mol Immunol"},{"key":"2164_CR24","doi-asserted-by":"publisher","first-page":"e74681","DOI":"10.7554\/eLife.74681","volume":"11","author":"NJ Silverstein","year":"2022","unstructured":"Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, Boribong BP, et al. Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection. Elife. 2022;11:e74681. https:\/\/doi.org\/10.7554\/eLife.74681.","journal-title":"Elife"},{"key":"2164_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073572","author":"M Pritsch","year":"2021","unstructured":"Pritsch M, Radon K, Bakuli A, Le Gleut R, Olbrich L, Guggenb\u00fcehl Noller JM, et al. Prevalence and risk factors of infection in the representative COVID-19 cohort Munich. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18073572.","journal-title":"Int J Environ Res Public Health"},{"key":"2164_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1186\/s12889-020-09164-9","volume":"20","author":"K Radon","year":"2020","unstructured":"Radon K, Saathoff E, Pritsch M, Guggenb\u00fchl Noller JM, Kroidl I, Olbrich L, et al. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19). BMC Public Health. 2020;20:1036. https:\/\/doi.org\/10.1186\/s12889-020-09164-9.","journal-title":"BMC Public Health"},{"key":"2164_CR27","doi-asserted-by":"crossref","unstructured":"Brand I, Gilberg L, Bruger J, Gar\u00ed M, Wieser A, Eser TM, et al. Broad T cell targeting of structural proteins after SARS-CoV-2 infection: high throughput assessment of T cell reactivity using an automated interferon gamma release assay. Front Immunol 2021;12.","DOI":"10.3389\/fimmu.2021.688436"},{"key":"2164_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/ibd\/izaa316","volume":"27","author":"L Mazzurana","year":"2021","unstructured":"Mazzurana L, Bonfiglio F, Forkel M, D\u2019Amato M, Halfvarson J, Mj\u00f6sberg J. Crohn\u2019s disease is associated with activation of circulating innate lymphoid cells. Inflamm Bowel Dis. 2021;27:1128\u201338. https:\/\/doi.org\/10.1093\/ibd\/izaa316.","journal-title":"Inflamm Bowel Dis"},{"key":"2164_CR29","doi-asserted-by":"publisher","unstructured":"Kotecha N, Krutzik PO, Irish JM. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom 2010;Chapter 10:Unit10.17-Unit10.17. https:\/\/doi.org\/10.1002\/0471142956.cy1017s53.","DOI":"10.1002\/0471142956.cy1017s53"},{"key":"2164_CR30","doi-asserted-by":"publisher","first-page":"193947","DOI":"10.1155\/2009\/193947","volume":"2009","author":"WT Rogers","year":"2009","unstructured":"Rogers WT, Holyst HA. FlowFP: a bioconductor package for fingerprinting flow cytometric data. Adv Bioinform. 2009;2009:193947. https:\/\/doi.org\/10.1155\/2009\/193947.","journal-title":"Adv Bioinform"},{"key":"2164_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell. 2017;168:1086-1100.e10. https:\/\/doi.org\/10.1016\/j.cell.2017.02.021.","journal-title":"Cell"},{"key":"2164_CR32","doi-asserted-by":"publisher","first-page":"eabj8301","DOI":"10.1126\/sciimmunol.abj8301","volume":"7","author":"E Kokkinou","year":"2023","unstructured":"Kokkinou E, Pandey RV, Mazzurana L, Gutierrez-Perez I, Tibbitt CA, Weigel W, et al. CD45RA+CD62L\u2212 ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs. Sci Immunol. 2023;7:eabj8301. https:\/\/doi.org\/10.1126\/sciimmunol.abj8301.","journal-title":"Sci Immunol"},{"key":"2164_CR33","doi-asserted-by":"crossref","unstructured":"Fonseca W, Lukacs NW, Elesela S, Malinczak C-A. Role of ILC2 in Viral-Induced Lung Pathogenesis. Front Immunol 2021;12.","DOI":"10.3389\/fimmu.2021.675169"},{"key":"2164_CR34","doi-asserted-by":"publisher","first-page":"e58838","DOI":"10.7554\/eLife.58838","volume":"10","author":"G Vanoni","year":"2021","unstructured":"Vanoni G, Ercolano G, Candiani S, Rutigliani M, Lanata M, Derr\u00e9 L, et al. Human primed ILCPs support endothelial activation through NF-\u03baB signaling. Elife. 2021;10:e58838. https:\/\/doi.org\/10.7554\/eLife.58838.","journal-title":"Elife"},{"key":"2164_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150862","author":"R Kaiser","year":"2021","unstructured":"Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.150862.","journal-title":"JCI Insight"},{"key":"2164_CR36","doi-asserted-by":"crossref","unstructured":"Sabbatino F, Conti V, Franci G, Sellitto C, Manzo V, Pagliano P, et al. PD-L1 dysregulation in COVID-19 patients. Front Immunol 2021;12.","DOI":"10.3389\/fimmu.2021.695242"},{"key":"2164_CR37","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12879-021-06457-1","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Ai G, Chen L, Liu S, Gong C, Zhu X, et al. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:738. https:\/\/doi.org\/10.1186\/s12879-021-06457-1.","journal-title":"BMC Infect Dis"},{"key":"2164_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","volume":"22","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43\u201355. https:\/\/doi.org\/10.1016\/S1473-3099(21)00460-6.","journal-title":"Lancet Infect Dis"},{"key":"2164_CR39","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41467-022-35240-2","volume":"13","author":"K Magnusson","year":"2022","unstructured":"Magnusson K, Kristoffersen DT, Dell\u2019Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13:7363. https:\/\/doi.org\/10.1038\/s41467-022-35240-2.","journal-title":"Nat Commun"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-02164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-023-02164-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-02164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T13:09:44Z","timestamp":1717160984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-023-02164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1007\/s15010-023-02164-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.02.23289345","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no commercial or financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"KoCo19-Shield: The study protocol was reviewed and approved by the Institutional Review Board of the Medical Faculty at Ludwig-Maximilians-University Munich, Germany under the project number 20-692 (vote of approval dated Sept. 21st, 2020) and 20-371 (vote of approval dated May 15th, 2020). Oral and written informed consent was obtained from all study subjects. PCC: The study protocol was reviewed and approved by the Institutional Review Board of the Medical Faculty at Ludwig-Maximilians-University Munich, Germany under the project number 21-1165 (vote of approval dated Feb 15, 2021, amendment approved Aug. 11, 2021). Oral and written informed consent was obtained from all study subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement for human studies"}},{"value":"The patients\/participants provided their written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}